We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Designed to help improve consistency and reliability of intradermal inject.
West is pleased to announce that it has received CE approval of the Intradermal (ID) Adapter. West received 510K clearance for the ID Adapter from the United States Food and Drug Administration in February 2013.
The ID adapter is designed to help improve the consistency and reliability of intradermal injections providing increased confidence for clinical trial results and better patient outcomes. The system will complement West’s portfolio of medical devices including reconstitution, safety and transfer systems.
Correctly administered ID injections can help conserve the supply of high-value vaccines and provide patients significant benefit through more reliable injection. The ID Adapter provides an alternative to the Mantoux method, the industry standard for intradermal injection since 1907. The Mantoux method requires extensive training and experience to perform correctly and consistently, whereas the ID Adapter enables this process to be carried out more easily, with less training and with greater reliability.
West conducted two clinical studies that verified the performance of the ID adapter. These studies confirmed a strong clinician preference for the ID adapter.
“We are delighted to offer our European customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area,” said Zach Marks, Marketing Director, Pharmaceutical Delivery Systems, West. Click here for more information on the ID Adapter technology.
Vaccines have helped reduce the instance of infectious diseases around the globe, nearly eradicating past plagues, such as smallpox and polio. A very effective method of delivery is intradermal (ID) injection – now made easier with two novel products on the market.
In a <a href="/zh-cn/blog/2017/july/new-technology-for-delivery-of-vaccines">previous blog post</a>, we discussed various devices and solutions used to overcome the challenges associated with Intradermal (ID) injections. These challenges are mainly associated with the Mantoux Technique, a manual ID injection using a needle and syringe. Lacking the skill needed for this technique creates a risk of injecting the product too deep or not sufficiently deep and rendering the dose either less or potentially ineffective. Previous posts also touched on some of the potential benefits associated with ID delivery when compared to the more familiar Subcutaneous or Intramuscular type injections. Two of the benefits we look at closer in this post are dose sparing and improved immune response. Additionally, we will see how these two benefits can be related. <br />
Vial adapters are a cost-effective solution for the safe and rapid reconstitution and transfer of drug products. They not only provide needle-free transfer of liquid for reconstitution, but also enable consistent withdrawal of drug product from a vial. By providing such consistent withdrawal, the use of vial adapters can aid in reducing the amount of required overfill (extra drug product in a vial to address the fact that not all drug product can be removed), which may result in cost savings.
<p><em>Harold Murray, Project Engineer, and Robert Froio, Intern, West Pharmaceutical Services, Inc.</em></p><p>Flange strength and dimensional variability are critical attributes when designing or selecting an auto-injector device to use in conjunction with a 1mL long syringe. Studies were performed to compare these attributes using Daikyo Crystal Zenith® (CZ) 1mL long syringes and glass 1mL long syringes.</p>
Microneedles have been around for the past two decades; however, recent advances in technology have enabled their manufacturing in a variety of different forms and at lower cost than previously possible. The technologies, ranging from hollow, solid, coated to dissolving, have captured the interest of many vaccine and drug manufacturers as an alternate form of delivery primarily due to the potential advantages associated with transdermal and intradermal delivery.<br />
English
Chinese
